Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Option Care Health, Inc.
Next earnings Jul 28, 2026 · consensus $0.44 EPS, $1.45B rev
Last earnings -24.3% on 2026-04-30
Revenue grew 13.0% YoY.
Fundamentals and price both look middling — no strong edge either way.
Sources: SEC EDGAR (CIK 0001014739, latest 10-Q filed 2026-04-30) · EODHD · as of 6/22/2026, 8:51:04 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
Option Care Health, Inc. shows $5.65B in FY2025 revenue (+13.0% YoY), a 3.7% net margin, and 15.7% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.44B | $3.87B | $4.30B | $5.00B | $5.65B |
| Gross profit | $780M | $867M | $981M | $1.01B | $1.09B |
| Operating income | $191M | $240M | $315M | $322M | $338M |
| Net income | $140M | $151M | $267M | $212M | $208M |
| Diluted EPS | $0.77 | $0.83 | $1.48 | $1.23 | $1.27 |
| Net margin | 4.1% | 3.9% | 6.2% | 4.2% | 3.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-05-20 | Bierbower Elizabeth D Director | Award | 9.00K | |
| 2026-05-20 | Deckmann Natasha Director | Award | 9.00K | |
| 2026-05-20 | Deckmann Natasha Director | Award | 844.00 @ $22.23 | $18.8K |
| 2026-05-20 | KRAEMER HARRY M JANSEN JR Director | Award | 9.00K | |
| 2026-05-20 | KRAEMER HARRY M JANSEN JR Director | Award | 12.1K @ $22.23 | $269K |
| 2026-05-20 | Pate R Carter Director | Award | 9.00K | |
| 2026-05-20 | SULLIVAN TIMOTHY P Director | Award | 9.00K | |
| 2026-05-20 | SULLIVAN TIMOTHY P Director | Award | 4.84K @ $22.23 | $108K |
| 2026-05-20 | Bodem Barbara W. Director | Award | 9.00K | |
| 2026-05-20 | Wright Norman L. Director | Award | 9.00K | |
| 2026-05-20 | BRANDT ERIC Director | Award | 9.00K | |
| 2026-05-20 | BRANDT ERIC Director | Award | 2.64K @ $22.23 | $58.8K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.